Literature DB >> 19225798

The nasal seromucinous glands after endoscopic sphenopalatine artery coagulation.

Samy Elwany1, Ayman Moustafa Al-Medany, Hoda Mahmoud Khalifa, Sedik Abdel Salam, Ahmed Soliman, Osama Abu el-Kheir.   

Abstract

Endoscopic coagulation of the sphenopalatine artery (SPA) is indicated in patients with recurrent or severe posterior epistaxis. The present work aimed at studying the effects of the sphenopalatine artery coagulation on the nasal seromucinous glands. The study was carried out on 30 patients who were scheduled for endoscopic SPA coagulation. All patients signed informed consents that were approved by the Committee of Medical Ethics. Minute punch biopsies were taken from the inferior turbinates, under local anesthesia, just before the procedure as well as 12 weeks and 1 year postoperatively. The biopsies were stained with hematoxylin and eosin and PAS Alcian blue. Histochemical examination was done for the activity of the succinic dehydrogenase, alkaline phosphatase and cholinesterase enzymes. Morphometric analysis as well as analysis of the histological and histochemical results showed that SPA coagulation was followed by an early decrease in the size, number and secretory activity of the nasal seromucinous glands, which was associated with decreased activity of the alkaline phosphatase enzyme in the endothelial cells of the nasal blood vessels and decreased activity of the cholinesterase enzyme in the cholinergic nerve fibers. These changes, however, were temporary and reversible since examination of the late postoperative biopsies, at 1 year, showed normalization of the number, appearance, and histochemical activity of the glandular acini as well as the surrounding blood vessels and cholinergic nerve fibers.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19225798     DOI: 10.1007/s00405-009-0917-8

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  17 in total

1.  Microscopic and endoscopic ligature of the sphenopalatine artery.

Authors:  R Budrovich; R Saetti
Journal:  Laryngoscope       Date:  1992-12       Impact factor: 3.325

2.  Cytochemical demonstration of succinic dehydrogenase by the use of a new p-nitrophenyl substituted ditetrazole.

Authors:  M M NACHLAS; K C TSOU; E DE SOUZA; C S CHENG; A M SELIGMAN
Journal:  J Histochem Cytochem       Date:  1957-07       Impact factor: 2.479

Review 3.  Sphenopalatine artery ligation: technical note.

Authors:  David D Pothier; Samuel Mackeith; Robin Youngs
Journal:  J Laryngol Otol       Date:  2005-10       Impact factor: 1.469

4.  Oroantral fistula: a complication of transantral ligation of the internal maxillary artery for epistaxis.

Authors:  M K Morgan; C P Aldren
Journal:  J Laryngol Otol       Date:  1997-05       Impact factor: 1.469

5.  Endoscopic ligation or diathermy of the sphenopalatine artery in persistent epistaxis.

Authors:  H R Sharp; J M Rowe-Jones; G S Biring; I S Mackay
Journal:  J Laryngol Otol       Date:  1997-11       Impact factor: 1.469

6.  Endoscopic ligation of the sphenopalatine artery (ELSA): a preliminary description.

Authors:  P S White
Journal:  J Laryngol Otol       Date:  1996-01       Impact factor: 1.469

7.  Endoscopic sphenopalatine artery ligation for refractory posterior epistaxis.

Authors:  Alok Thakar; Cj Sharan
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2005-07

8.  Sphenopalatine artery ligation: an alternative to internal maxillary artery ligation for intractable posterior epistaxis.

Authors:  W Winstead
Journal:  Laryngoscope       Date:  1996-05       Impact factor: 3.325

9.  Clinical evaluation of vidian neurectomy for nasal allergy.

Authors:  M Sadanaga
Journal:  Auris Nasus Larynx       Date:  1989       Impact factor: 1.863

10.  Effect of internal maxillary arterial occlusion on nasal blood flow in swine.

Authors:  E M Weaver; J C Chaloupka; C M Putman; T C Roth; J K Horky; C T Sasaki
Journal:  Laryngoscope       Date:  1999-01       Impact factor: 3.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.